当前位置:首页 > 股票大全 > 西藏药业 600211 财务分析

西藏药业财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

西藏药业(600211)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入704,221,182.533,134,328,350.182,368,009,918.391,820,236,994.97
营业总成本444,139,520.22,058,296,534.761,546,792,565.351,167,604,227.1
营业利润347,266,516.45899,092,953.3954,751,255.42664,461,300.58
利润总额347,440,052.38898,194,826.94954,669,621.35664,236,206.45
净利润315,241,177.6810,244,835.23863,520,088.44599,834,323.17
其他综合收益1,815,542.1418,235,579.0734,921,617.5441,662,632.69
综合收益总额317,056,719.74828,480,414.3898,441,705.98641,496,955.86
西藏药业(600211)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计3,916,998,705.033,402,862,444.973,343,904,2263,478,404,506.98
非流动资产合计1,172,481,531.921,184,494,664.841,377,510,436.751,371,154,395.33
资产总计5,089,480,236.954,587,357,109.814,721,414,662.754,849,558,902.31
流动负债合计1,367,078,135.261,184,470,348.441,231,588,160.721,319,577,461.18
非流动负债合计30,274,669.0729,266,048.4843,565,114.4542,643,516.39
负债合计1,397,352,804.331,213,736,396.921,275,153,275.171,362,220,977.57
归属于母公司股东权益合计3,659,323,698.643,344,589,024.493,419,052,368.053,464,377,524.06
股东权益合计3,692,127,432.623,373,620,712.893,446,261,387.583,487,337,924.74
负债和股东权益合计5,089,480,236.954,587,357,109.814,721,414,662.754,849,558,902.31
西藏药业(600211)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,111,241,958.293,530,503,370.612,772,639,447.81,838,752,293.82
经营活动现金流出小计675,064,182.482,467,081,567.881,989,354,937.551,293,900,202.99
经营活动产生的现金流量净额436,177,775.811,063,421,802.73783,284,510.25544,852,090.83
投资活动现金流入小计1,044,743,172.093,011,255,163.252,171,462,711.381,318,018,396.74
投资活动现金流出小计1,384,328,298.733,843,138,943.162,487,874,786.951,840,601,350.5
投资活动产生的现金流量净额-339,585,126.64-831,883,779.91-316,412,075.57-522,582,953.76
筹资活动现金流入小计261,566,016.54701,724,187.25605,000,000381,900,000
筹资活动现金流出小计2,289,385.111,185,409,494.63827,425,124.64428,821,496.09
筹资活动产生的现金流量净额259,276,631.43-483,685,307.38-222,425,124.64-46,921,496.09
汇率变动对现金及现金等价物的影响2,047,665.487,040,947.1215,071,950.3829,561,282.32
现金及现金等价物净增加额357,916,946.08-245,106,337.44259,519,260.424,908,923.3
期末现金及现金等价物余额1,040,096,508.32682,179,562.241,186,805,160.1932,194,822.98
西藏药业600211相关数据
今日股市大盘指数